
NovaSignal Corp: A med-tech firm using AI and robotics for real-time cerebral blood flow analysis.
Founded with the mission to save lives by unlocking the hidden power of blood flow data, NovaSignal Corp. is a pioneering medical technology company. The company offers the FDA-cleared NovaGuide™ Intelligent Ultrasound, which integrates non-invasive ultrasound, robotics, and artificial intelligence to provide real-time cerebral blood flow analysis. NovaSignal targets the healthcare market, focusing on improving diagnostics and patient outcomes through advanced blood flow monitoring.
Notable figures associated with NovaSignal include leading experts in medical technology and artificial intelligence. The company has attracted significant investment from prominent venture capital firms, bolstering its research and development capabilities. Key achievements include receiving FDA clearance for their flagship product and establishing partnerships with major healthcare institutions. NovaSignal's innovative approach has significantly impacted the medical field by enhancing the accuracy and efficiency of cerebral blood flow assessments.

Novela Neurotech
novelaneuro.com

Neuro42

StrokeDx
stroke-dx.com

RapidAI
rapidai.com

Neuroview Technology
neuroviewtech.com

EchoNous
echonous.com

Neurvana Medical

Ainnova Tech
ainnovatech.com

Neurosonics Medical

NeuroFieldz
neurofieldz.com

Scinovia

BrainSpace
brainspacemed.com

LivaNova
livanova.com

RAD AI
radai.com

NextSense
nextsense.io
Companies similar to NovaSignal include Novela Neurotech, Neuro42, StrokeDx and RapidAI.
NovaSignal was founded in 2013.
NovaSignal's headquarters is located in Los Angeles, CA, US.
NovaSignal's most recent funding round was for $37M (USD) in September 2021.
As of Sep 28, 2021, NovaSignal has raised a total of $127.9M (USD).
NovaSignal has 88 employees as of Feb 5, 2024.